Back to Top

HIV Prevention and Treatment

Get Help with Your Treatment

Apply Online or call 1-866-316-7263

 

Program Status

Fully Allocated – We are no longer accepting or processing applications for new or renewal patients.

 

The PAN Foundation’s HIV Treatment and Prevention fund is currently fully allocated. As of February 23, 2017, Patient Advocate Foundation is accepting applications.

 

 

 

 

Maximum Award Level

$8,000 per year. Patients may apply for a second grant during their eligibility period subject to availability of funding.

Eligibility Criteria

  1. The patient must be getting treatment for the disease named in the assistance program to which he or she is applying.
  2. The patient must have Medicare health insurance that covers his or her qualifying medication or product. 
  3.  
  4. The patient’s medication or product must be listed on PAN’s list of covered medications.
  5. The patient’s income must fall at or below 500% of the Federal Poverty Level.
  6. The patient must reside and receive treatment in the United States or U.S. territories. (U.S. citizenship is not a requirement.)
list icon
See the list of medications covered in this program
View List  
  • Aptivus (tipranavir (TPV))
  • Atripla (efavirenz/emtricitabine/tenofovir)
  • Combivir (lamivudine/zidovudine)
  • Complera (emtricitabine/rilpivirine/tenofovir)
  • Crixivan (indinavir (IDV))
  • Descovy (emtricitabine/tenofovir)
  • Didanosine (didanosine (ddI))
  • Edurant (rilpivirine (RPV))
  • Emtriva (emtricitabine (FTC))
  • Epivir (lamivudine)
  • Epivir HBV (lamivudine)
  • Epzicom (abacavir/lamivudine)
  • Evotaz (atazanavir/cobicistat)
  • Fuzeon (enfuvirtide (T20))
  • Genvoya (elvitegravir/cobicistat/emtricitabine/tenofovir)
  • Intelence (etravirine (ETR))
  • Invirase (saquinavir (SQV))
  • Isentress (raltegravir (RAL))
  • Kaletra (lopinavir/ritonavir)
  • Lexiva (fosamprenavir (FPV))
  • Norvir (ritonavir (RTV))
  • Odefsey (emtricitabine-rilpivirine-tenofovir)
  • Prezcobix (darunavir/cobicistat)
  • Prezista (darunavir (DRV))
  • Rescriptor (delavirdine (DLV))
  • Retrovir (zidovudine)
  • Retrovir IV Infusion (zidovudine)
  • Reyataz (atazanavir (ATV))
  • Selzentry (maraviroc (MVC))
  • Stribild (cobicistat/elvitegravir/emtricitabine/tenofovir)
  • Sustiva (efavirenz (EFV))
  • Tivicay (dolutegravir)
  • Triumeq (abacavir/dolutegravir lamivudine)
  • Trizivir (abacavir/lamivudine/zidovudine)
  • Truvada (emtricitabine/tenofovir)
  • Tybost (cobistat)
  • Videx (didanosine (ddI))
  • Videxpediatric (didanosine (ddI))
  • Viracept (nelfinavir (NFV))
  • Viramune (nevirapine)
  • Viramune XR (nevirapine)
  • Viread (tenofovir (TDF))
  • Vitekta (elvitegravir)
  • Zerit (stavudine)
  • Ziagen (abacavir)
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  

Diagnosis Codes:

ICD-10: B17.10, B17.11, B18.2, B19.20, B19.21